MNPR vs AMZN · $431.4M cap vs P/E 31, rev $716.92B
Monopar Therapeutics Inc (MNPR) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
MNPR currently screens at market cap $431.4M. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the MNPR and AMZN stock pages for the full models.
Not investment advice.